6Perou CM , Sorlie T, Eisen MB , et aL Molecular portraits of human breast turnouts [ J ] . Nature, 2000, 406 ( 6797 ) : 747-752.
7Van Calster B, Vanden Bempt I, Drijkoningen M, et al. Axillary lymph node status of oper0ble breast cancers by combined steroid receptor and HER-2 status : triple positive tumours are more likely lymph node positive [ J ] . Breast Cancer Res Treat, 2009, 113 ( 1 ) : 181-187.
8Dunnwald LK, Rossing MA, Li CI. Hormone receptor status, tumor characteristics, and prognosis : a prospective cohort of breast cancer patients [ J ] . Breast Cancer Res, 2007, 9 ( 1 ) : R6.
9Huang HJ, Neven P, Drijkoningen M, et al. Association between tumour characteristics and HER-2/neu by immunohistochemistry in 1362 women with primary operable breast cancer [ J ] . J Clin Pathol, 2005, 58 (6) : 611-616.
10Lange CA, Richer JK, Shen T, et al. Convergence of progesterone and epidermal growth factor signaling in breast cancer. Potentiation of mitogen-activated protein kinase pathways [J]. J Biol Chem, 1998, 273 (47) : 31308-31316.
